World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
92
Citations
19841
World Ranking
1015
National Ranking
550

Medicine

D-Index
92
Citations
20012
World Ranking
11469
National Ranking
5878

Cory M. Hogaboam publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cory M. Hogaboam sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 349 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cory M. Hogaboam D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cory M. Hogaboam sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cory M. Hogaboam is affiliated with the Cedars-Sinai Medical Center in the United States. Their primary field of study is Medicine, with a focus on Pulmonary and Respiratory Medicine. Additional areas of work include Molecular Biology, Immunology, Surgery, and Physiology.

The research topics extensively covered by Hogaboam include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neonatal Respiratory Health Research
  • Medical Imaging and Pathology Studies
  • Occupational and Environmental Lung Diseases
  • Congenital Diaphragmatic Hernia Studies
  • Respiratory Support and Mechanisms
  • Extracellular Vesicles in Disease

Hogaboam has contributed to numerous publications, frequently collaborating with co-authors such as Barry R. Stripp, Ana Lúcia Coelho, Changfu Yao, Milena S. Espíndola, and Peter Chen. The most common venues where their work appears are:

  • American Journal of Respiratory and Critical Care Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • iScience
  • JCI Insight
  • Nature Communications

Selected recent papers illustrating the scope of Hogaboam's research include:

  • Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs, 2020, American Journal of Respiratory and Critical Care Medicine
  • Categorization of Lung Mesenchymal Cells in Development and Fibrosis, 2021, iScience
  • Increased Expression and Accumulation of GDF15 in IPF Extracellular Matrix Contribute to Fibrosis, 2022, JCI Insight
  • Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis, 2020, American Journal of Respiratory and Critical Care Medicine
  • Immune Mechanisms in Fibrotic Interstitial Lung Disease, 2024, Cell

Best Publications

  • Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

    Timothy S. Blackwell;Andrew M. Tager;Zea Borok;Bethany B. Moore

  • Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease

    Ruoqi Peng;Sriram Sridhar;Gaurav Tyagi;Jonathan E Phillips

  • Epigenetic regulation of dendritic cell–derived interleukin-12 facilitates immunosuppression after a severe innate immune response

    Haitao Wen;Yali Dou;Cory M. Hogaboam;Steven L. Kunkel

  • MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays

    Jannie Marie Sand;Lise Skakkebæk Larsen;Cory Hogaboam;Fernando Martinez

  • The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat

    Maureen N. Ajuebor;Cory M. Hogaboam;Steven L. Kunkel;Amanda E. I. Proudfoot

  • Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes

    Katherine A. Gallagher;Amrita Joshi;William F. Carson;Matthew Schaller

  • MIP‐1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF‐α and LTB4

    Cleber D. L. Ramos;Claudio Canetti;Claudio Canetti;Janeusa T. Souto;Janeusa T. Souto;João S. Silva

  • Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.

    Lynne A Murray;Rogério S. Rosada;Ana Paula Duarte Moreira;Amrita D Joshi

  • Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction

    Guo Yun Chen;Xi Chen;Samantha King;Karen A. Cavassani

  • Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling

    Steven Kenneth Huang;Scott H Wettlaufer;Cory M Hogaboam;David M Aronoff

  • The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

    DN O'Dwyer;ME Armstrong;G Trujillo;G Cooke

  • Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.

    Cory M. Hogaboam;Cynthia L. Bone-Larson;Scott Lipinski;Nicholas W. Lukacs

  • Novel Role of Transmembrane SCF for Mast Cell Activation and Eotaxin Production in Mast Cell-Fibroblast Interactions

    Cory Hogaboam;Steven L. Kunkel;Robert M. Strieter;Dennis D. Taub

  • Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2

    Lynne A. Murray;Rochelle L. Argentieri;Francis X. Farrell;Michelle Bracht

  • Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice.

    Jane M. Schuh;Christine A. Power;Amanda E. Proudfoot;Steven L. Kunkel

  • Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.

    Miriam S. Hohmann;David M. Habiel;Ana L. Coelho;Waldiceu A. Verri

  • Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes

    Nicolai A. Kittan;Ronald M. Allen;Abhay Dhaliwal;Karen A. Cavassani

  • Reversal of long-term sepsis-induced immunosuppression by dendritic cells.

    Claudia F. Benjamim;Steven K. Lundy;Nicholas W. Lukacs;Cory M. Hogaboam

  • Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2−/− Mice

    Kate Blease;Borna Mehrad;Theodore J. Standiford;Nicholas W. Lukacs

  • Hypermethylation of PTGER2 Confers Prostaglandin E2 Resistance in Fibrotic Fibroblasts from Humans and Mice

    Steven K. Huang;Aaron S. Fisher;Anne M. Scruggs;Eric S. White

  • Macrophages in Allergic Asthma: Fine-Tuning Their Pro- and Anti-Inflammatory Actions for Disease Resolution

    Ana Paula Moreira;Cory M. Hogaboam

  • Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2

    Cory M. Hogaboam;Cynthia L. Bone-Larson;Matthew L. Steinhauser;Akihiro Matsukawa

Frequent Co-Authors

Steven L. Kunkel
Steven L. Kunkel University of Michigan–Ann Arbor
Nicholas W. Lukacs
Nicholas W. Lukacs University of Michigan–Ann Arbor
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Robert M. Strieter
Robert M. Strieter University of Virginia
Stephen W. Chensue
Stephen W. Chensue University of Michigan–Ann Arbor
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Galen B. Toews
Galen B. Toews University of Michigan–Ann Arbor
Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Theodore J. Standiford
Theodore J. Standiford University of Michigan–Ann Arbor
Darryl A. Knight
Darryl A. Knight University of Newcastle Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse career options in healthcare and research. For those interested in nursing, specialized programs such as the cheapest pmhnp programs online offer affordable pathways to become Psychiatric-Mental Health Nurse Practitioners, emphasizing care for patients with complex immunological and neurological conditions.

Advanced practice nurses aiming to expand their expertise can explore bridge programs like the fnp to acnp bridge program online. These programs provide a streamlined transition from Family Nurse Practitioner to Acute Care Nurse Practitioner, focusing on critical patient management, often involving immune-related acute diseases.

The demand for highly trained nurse practitioners affects earning potential significantly. To understand financial prospects, reviewing data on how much do dnps make can help future graduates make informed decisions about their career paths in immunology-related healthcare fields.

For those seeking a faster route into nursing practice, accelerated nurse practitioner programs provide intensive training that combines foundational and advanced coursework, enabling quicker entry into specialized roles relevant to immunology and patient care.

Best Scientists Citing Cory M. Hogaboam

Trending Scientists